Cytokine plasma levels: reliable predictors for radiation pneumonitis?

<h4>Background</h4>Radiotherapy (RT) is the primary treatment modality for inoperable, locally advanced non-small-cell lung cancer (NSCLC), but even with highly conformal treatment planning, radiation pneumonitis (RP) remains the most serious, dose-limiting complication. Previous clinica...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Claudia E Rübe, Jan Palm, Michael Erren, Jochen Fleckenstein, Jochem König, Klaus Remberger, Christian Rübe
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2008
Materias:
R
Q
Acceso en línea:https://doaj.org/article/2fbaec7801824f0391e82b1e8577df47
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:2fbaec7801824f0391e82b1e8577df47
record_format dspace
spelling oai:doaj.org-article:2fbaec7801824f0391e82b1e8577df472021-11-25T06:11:17ZCytokine plasma levels: reliable predictors for radiation pneumonitis?1932-620310.1371/journal.pone.0002898https://doaj.org/article/2fbaec7801824f0391e82b1e8577df472008-08-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18682839/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Radiotherapy (RT) is the primary treatment modality for inoperable, locally advanced non-small-cell lung cancer (NSCLC), but even with highly conformal treatment planning, radiation pneumonitis (RP) remains the most serious, dose-limiting complication. Previous clinical reports proposed that cytokine plasma levels measured during RT allow to estimate the individual risk of patients to develop RP. The identification of such cytokine risk profiles would facilitate tailoring radiotherapy to maximize treatment efficacy and to minimize radiation toxicity. However, cytokines are produced not only in normal lung tissue after irradiation, but are also over-expressed in tumour cells of NSCLC specimens. This tumour-derived cytokine production may influence circulating plasma levels in NSCLC patients. The aim of the present study was to investigate the prognostic value of TNF-alpha, IL-1beta, IL-6 and TGF-beta1 plasma levels to predict radiation pneumonitis and to evaluate the impact of tumour-derived cytokine production on circulating plasma levels in patients irradiated for NSCLC.<h4>Methodology/principal findings</h4>In 52 NSCLC patients (stage I-III) cytokine plasma levels were investigated by ELISA before and weekly during RT, during follow-up (1/3/6/9 months after RT), and at the onset of RP. Tumour biopsies were immunohistochemically stained for IL-6 and TGF-beta1, and immunoreactivity was quantified (grade 1-4). RP was evaluated according to LENT-SOMA scale. Tumour response was assessed according to RECIST criteria by chest-CT during follow-up. In our clinical study 21 out of 52 patients developed RP (grade I/II/III/IV: 11/3/6/1 patients). Unexpectedly, cytokine plasma levels measured before and during RT did not correlate with RP incidence. In most patients IL-6 and TGF-beta1 plasma levels were already elevated before RT and correlated significantly with the IL-6 and TGF-beta1 production in corresponding tumour biopsies. Moreover, IL-6 and TGF-beta1 plasma levels measured during follow-up were significantly associated with the individual tumour responses of these patients.<h4>Conclusions/significance</h4>The results of this study did not confirm that cytokine plasma levels, neither their absolute nor any relative values, may identify patients at risk for RP. In contrast, the clear correlations of IL-6 and TGF-beta1 plasma levels with the cytokine production in corresponding tumour biopsies and with the individual tumour responses suggest that the tumour is the major source of circulating cytokines in patients receiving RT for advanced NSCLC.Claudia E RübeJan PalmMichael ErrenJochen FleckensteinJochem KönigKlaus RembergerChristian RübePublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 3, Iss 8, p e2898 (2008)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Claudia E Rübe
Jan Palm
Michael Erren
Jochen Fleckenstein
Jochem König
Klaus Remberger
Christian Rübe
Cytokine plasma levels: reliable predictors for radiation pneumonitis?
description <h4>Background</h4>Radiotherapy (RT) is the primary treatment modality for inoperable, locally advanced non-small-cell lung cancer (NSCLC), but even with highly conformal treatment planning, radiation pneumonitis (RP) remains the most serious, dose-limiting complication. Previous clinical reports proposed that cytokine plasma levels measured during RT allow to estimate the individual risk of patients to develop RP. The identification of such cytokine risk profiles would facilitate tailoring radiotherapy to maximize treatment efficacy and to minimize radiation toxicity. However, cytokines are produced not only in normal lung tissue after irradiation, but are also over-expressed in tumour cells of NSCLC specimens. This tumour-derived cytokine production may influence circulating plasma levels in NSCLC patients. The aim of the present study was to investigate the prognostic value of TNF-alpha, IL-1beta, IL-6 and TGF-beta1 plasma levels to predict radiation pneumonitis and to evaluate the impact of tumour-derived cytokine production on circulating plasma levels in patients irradiated for NSCLC.<h4>Methodology/principal findings</h4>In 52 NSCLC patients (stage I-III) cytokine plasma levels were investigated by ELISA before and weekly during RT, during follow-up (1/3/6/9 months after RT), and at the onset of RP. Tumour biopsies were immunohistochemically stained for IL-6 and TGF-beta1, and immunoreactivity was quantified (grade 1-4). RP was evaluated according to LENT-SOMA scale. Tumour response was assessed according to RECIST criteria by chest-CT during follow-up. In our clinical study 21 out of 52 patients developed RP (grade I/II/III/IV: 11/3/6/1 patients). Unexpectedly, cytokine plasma levels measured before and during RT did not correlate with RP incidence. In most patients IL-6 and TGF-beta1 plasma levels were already elevated before RT and correlated significantly with the IL-6 and TGF-beta1 production in corresponding tumour biopsies. Moreover, IL-6 and TGF-beta1 plasma levels measured during follow-up were significantly associated with the individual tumour responses of these patients.<h4>Conclusions/significance</h4>The results of this study did not confirm that cytokine plasma levels, neither their absolute nor any relative values, may identify patients at risk for RP. In contrast, the clear correlations of IL-6 and TGF-beta1 plasma levels with the cytokine production in corresponding tumour biopsies and with the individual tumour responses suggest that the tumour is the major source of circulating cytokines in patients receiving RT for advanced NSCLC.
format article
author Claudia E Rübe
Jan Palm
Michael Erren
Jochen Fleckenstein
Jochem König
Klaus Remberger
Christian Rübe
author_facet Claudia E Rübe
Jan Palm
Michael Erren
Jochen Fleckenstein
Jochem König
Klaus Remberger
Christian Rübe
author_sort Claudia E Rübe
title Cytokine plasma levels: reliable predictors for radiation pneumonitis?
title_short Cytokine plasma levels: reliable predictors for radiation pneumonitis?
title_full Cytokine plasma levels: reliable predictors for radiation pneumonitis?
title_fullStr Cytokine plasma levels: reliable predictors for radiation pneumonitis?
title_full_unstemmed Cytokine plasma levels: reliable predictors for radiation pneumonitis?
title_sort cytokine plasma levels: reliable predictors for radiation pneumonitis?
publisher Public Library of Science (PLoS)
publishDate 2008
url https://doaj.org/article/2fbaec7801824f0391e82b1e8577df47
work_keys_str_mv AT claudiaerube cytokineplasmalevelsreliablepredictorsforradiationpneumonitis
AT janpalm cytokineplasmalevelsreliablepredictorsforradiationpneumonitis
AT michaelerren cytokineplasmalevelsreliablepredictorsforradiationpneumonitis
AT jochenfleckenstein cytokineplasmalevelsreliablepredictorsforradiationpneumonitis
AT jochemkonig cytokineplasmalevelsreliablepredictorsforradiationpneumonitis
AT klausremberger cytokineplasmalevelsreliablepredictorsforradiationpneumonitis
AT christianrube cytokineplasmalevelsreliablepredictorsforradiationpneumonitis
_version_ 1718414032718790656